Nexium, Prilosec, Similar Heartburn Drugs Linked To Potentially Fatal Skin Reactions: Study

Researchers indicate the side effects of Nexium, Prilosec and similar heartburn drugs may increase the risk of serious and potentially fatal skin reactions, raising further concerns about the safety of proton pump inhibitor (PPI) medications.

In findings published recently in the Journal of Cosmetic Dermatology, Lebanese researchers warn that use of a class of heartburn drugs known as proton pump inhibitors (PPIs) could result in immediate or delayed hypersensitivity reactions, with the problems primarily seen among some of the top selling medications on the market in the U.S., including Nexium, Prilosec, Zegerid and Prevacid.

PPIs are designed to reduce the amount of acid in the stomach, treating gastroesophageal reflux disease (GERD), as well as heartburn, ulcers in the stomach and small intestines, and inflammation of the esophagus. In addition to Nexium, Prevacid, Prilosec, Protonix and Zegerid, other drugs in the same class of medications include Protonix, AcipHex, Dexilant and Vimovo.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

In the study, researchers from Saint Georges Hospital University Medical Center in Beirut used data from 56 case reports, case series and review articles of skin reactions linked to PPI use and found a high rate of IgE-mediated allergic reactions, which cause adverse immune system responses from all PPI drugs. In addition, the researchers also found delayed-type hypersensitivity reactions, which can be lethal.

“PPI‐induced adverse skin reactions are mostly immunological and include both immediate and delayed‐type hypersensitivity reactions. These reactions are sometimes life‐threatening,” the researchers warned. “PPIs should be considered in our list of culprits when considering a patient with a cutaneous drug reaction, taking into account that these drugs can cause severe immunological manifestations.”

PPI Kidney Damage Lawsuits

While the drugs are used by millions of Americans and widely viewed as safe, concerns in recent years have mostly focused on the failure to warn about the risk of kidney damage and kidney failure among users.

There are currently more than 15,000 Nexium lawsuitsProtonix lawsuitsPrilosec lawsuitsPrevacid lawsuits  and claims over other PPIs pending in courts nationwide, each raising similar allegations that the manufacturers withheld information about the kidney risks for years, placing the desire for profits ahead of consumer safety.

Given similar questions of fact and law raised in the complaints, consolidated pretrial proceedings have been established in the federal court system, where all PPI kidney damage lawsuits are centralized before U.S. District Judge Claire C. Cecchi in the District of New Jersey to reduce duplicative discovery into common issues, avoid conflicting pretrial rulings and serve the convenience of the parties, witnesses and the courts.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

First Gardasil Lawsuit Set For Trial To Begin October 7th in California State Court
First Gardasil Lawsuit Set For Trial To Begin October 7th in California State Court (Posted yesterday)

The first Gardasil lawsuit will go to trial in California state court in October, as a group of cases at the federal level continue to be developed for future bellwether trials that are unlikely to begin until late 2025 or early 2026.

Tepezza Settlement Talks For Hearing Loss Claims Will Commence Next Month
Tepezza Settlement Talks For Hearing Loss Claims Will Commence Next Month (Posted yesterday)

Parties have been directed to meet quarterly for mediation sessions, which will explore the potential for Tepezza hearing loss settlements, as the talks leading up to the first bellwether trials, slated to begin in March 2026.